Logo Logo
Eine Ebene nach oben
Exportieren als [feed] RSS 1.0 [feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 6 .

Zeitschriftenartikel

Harbeck, Nadia; Gluz, Oleg; Christgen, Matthias; Kates, Ronald Ernest; Braun, Michäl; Küemmel, Sherko; Schumacher, Claudia; Potenberg, Jochem; Krämer, Stefan; Kleine-Tebbe, Anke; Augustin, Doris; Aktas, Bahriye; Forstbauer, Helmut; Tio, Joke; Schumann, Raquel von; Liedtke, Cornelia; Grischke, Eva-Maria; Schumacher, Johannes; Würstlein, Rachel; Kreipe, Hans Heinrich; Nitz, Ulrike Anneliese (2017): De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early BC HER2-and Hormone Receptor-Positive Phase II Randomized Trial-Efficacy, Safety, and Predictive Markers for 12 Weeks of Neoadjuvant Trastuzumab Emtansine With or Without Endocrine Therapy (ET) Versus Trastuzumab Plus ET. In: Journal of Clinical Oncology, Vol. 35, Nr. 26: S. 3046-3056

Nitz, Ulrike; Gluz, Oleg; Christgen, Matthias; Kates, Ronald E.; Clemens, Michael; Malter, Wolfram; Nuding, Benno; Aktas, Bahriye; Kümmel, Sherko; Reimer, Toralf; Stefek, Andrea; Lorenz-Salehi, Fatemeh; Krabisch, Petra; Just, Marianne; Augustin, Doris; Liedtke, Cornelia; Chao, Calvin; Shak, Steven; Würstlein, Rachel; Kreipe, Hans H.; Harbeck, Nadia (2017): Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial. In: Breast Cancer Research and Treatment, Vol. 165, Nr. 3: S. 573-583

Banys-Paluchowski, Malgorzata; Witzel, Isabell; Riethdorf, Sabine; Rack, Brigitte; Janni, Wolfgang; Fasching, Peter Andreas; Solomayer, Erich-Franz; Aktas, Bahriye; Kasimir-Bauer, Sabine; Pantel, Klaus; Fehm, Tanja; Müller, Volkmar (2017): Clinical Relevance of Serum HER2 and Circulating Tumor Cell Detection in Metastatic Breast Cancer Patients. In: Anticancer Research, Vol. 37, Nr. 6: S. 3117-3128

Gluz, Oleg; Nitz, Ulrike A.; Christgen, Matthias; Kates, Ronald E.; Shak, Steven; Clemens, Michael; Kraemer, Stefan; Aktas, Bahriye; Kuemmel, Sherko; Reimer, Toralf; Kusche, Manfred; Heyl, Volker; Lorenz-Salehi, Fatemeh; Just, Marianne; Hofmann, Daniel; Degenhardt, Tom; Liedtke, Cornelia; Svedman, Christer; Wuerstlein, Rachel; Kreipe, Hans H.; Harbeck, Nadia (2016): West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment. In: Journal of Clinical Oncology, Vol. 34, Nr. 20: 2341-U66

Mueller, Volkmar; Riethdorf, Sabine; Rack, Brigitte; Janni, Wolfgang; Fasching, Peter A.; Solomayer, Erich; Aktas, Bahriye; Kasimir-Bauer, Sabine; Pantel, Klaus; Fehm, Tanja: Prognostic impact of circulating tumor cells assessed with the CellSearch System (TM) and AdnaTest Breast (TM) in metastatic breast cancer patients: the DETECT study. In: Breast Cancer Research 2012, 14:R118 [PDF, 378kB]

Mueller, Volkmar; Riethdorf, Sabine; Rack, Brigitte; Janni, Wolfgang; Fasching, Peter A.; Solomayer, Erich; Aktas, Bahriye; Kasimir-Bauer, Sabine; Zeitz, Julia; Pantel, Klaus; Fehm, Tanja: Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer. In: Breast Cancer Research 2011, 13:R71 [PDF, 432kB]

Diese Liste wurde am Wed Jun 20 23:01:53 2018 CEST erstellt.